Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cephamycins | 5 | 1993 | 10 | 0.300 |
Why?
|
| Cephalosporins | 8 | 1993 | 59 | 0.290 |
Why?
|
| Education, Medical | 3 | 2000 | 147 | 0.230 |
Why?
|
| Anti-Bacterial Agents | 11 | 1988 | 1026 | 0.220 |
Why?
|
| Bacteroides fragilis | 7 | 1993 | 20 | 0.210 |
Why?
|
| Microbial Sensitivity Tests | 8 | 1993 | 226 | 0.170 |
Why?
|
| Telecommunications | 1 | 1999 | 31 | 0.170 |
Why?
|
| Curriculum | 3 | 2000 | 575 | 0.170 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 1993 | 121 | 0.120 |
Why?
|
| Schools, Medical | 3 | 2000 | 157 | 0.120 |
Why?
|
| Bacteria, Anaerobic | 1 | 1991 | 15 | 0.100 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1993 | 226 | 0.100 |
Why?
|
| Skin Diseases, Infectious | 1 | 1988 | 16 | 0.080 |
Why?
|
| beta-Lactamases | 3 | 1987 | 33 | 0.080 |
Why?
|
| Staphylococcus | 2 | 1986 | 29 | 0.080 |
Why?
|
| Fever of Unknown Origin | 1 | 1987 | 3 | 0.080 |
Why?
|
| Bacteroides | 3 | 1977 | 7 | 0.070 |
Why?
|
| Methicillin | 1 | 1986 | 11 | 0.070 |
Why?
|
| Gram-Negative Anaerobic Bacteria | 1 | 1985 | 3 | 0.060 |
Why?
|
| Penicillinase | 2 | 1976 | 3 | 0.060 |
Why?
|
| Bacterial Infections | 3 | 1979 | 163 | 0.060 |
Why?
|
| Amidohydrolases | 2 | 1976 | 60 | 0.060 |
Why?
|
| Drug Resistance, Microbial | 6 | 1986 | 70 | 0.060 |
Why?
|
| Cefoxitin | 4 | 1991 | 20 | 0.050 |
Why?
|
| Clindamycin | 4 | 1987 | 25 | 0.050 |
Why?
|
| Hypertriglyceridemia | 1 | 2000 | 21 | 0.050 |
Why?
|
| HIV Protease Inhibitors | 1 | 2000 | 25 | 0.050 |
Why?
|
| Fenofibrate | 1 | 2000 | 23 | 0.050 |
Why?
|
| Hypolipidemic Agents | 1 | 2000 | 82 | 0.040 |
Why?
|
| Fetal Membranes, Premature Rupture | 2 | 1979 | 45 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1987 | 2324 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2000 | 403 | 0.040 |
Why?
|
| Escherichia coli | 2 | 1976 | 368 | 0.040 |
Why?
|
| Cephalosporinase | 1 | 1976 | 1 | 0.040 |
Why?
|
| Clostridium | 1 | 1976 | 10 | 0.030 |
Why?
|
| Fusobacterium | 2 | 1987 | 2 | 0.030 |
Why?
|
| Anaerobiosis | 5 | 1977 | 44 | 0.030 |
Why?
|
| Conjugation, Genetic | 1 | 1976 | 7 | 0.030 |
Why?
|
| Humans | 20 | 2000 | 68549 | 0.030 |
Why?
|
| Palpation | 2 | 1986 | 21 | 0.030 |
Why?
|
| Penicillins | 3 | 1987 | 32 | 0.030 |
Why?
|
| South Carolina | 2 | 2000 | 2752 | 0.030 |
Why?
|
| Cefotaxime | 2 | 1991 | 7 | 0.030 |
Why?
|
| Lymphopenia | 1 | 1993 | 12 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 1993 | 94 | 0.030 |
Why?
|
| Drug Synergism | 1 | 1993 | 260 | 0.030 |
Why?
|
| Cefotetan | 1 | 1991 | 3 | 0.030 |
Why?
|
| Ceftizoxime | 1 | 1991 | 3 | 0.030 |
Why?
|
| HIV-1 | 1 | 1993 | 177 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1991 | 137 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 1993 | 1040 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 1988 | 62 | 0.020 |
Why?
|
| Chemistry | 1 | 1988 | 45 | 0.020 |
Why?
|
| Gentamicins | 2 | 1982 | 68 | 0.020 |
Why?
|
| Breast | 2 | 1986 | 137 | 0.020 |
Why?
|
| Cesarean Section | 2 | 1979 | 101 | 0.020 |
Why?
|
| Metronidazole | 2 | 1979 | 28 | 0.020 |
Why?
|
| Surgical Wound Infection | 2 | 1982 | 168 | 0.020 |
Why?
|
| Administration, Oral | 1 | 1988 | 411 | 0.020 |
Why?
|
| Hydrolysis | 3 | 1981 | 144 | 0.020 |
Why?
|
| Teaching | 2 | 1986 | 169 | 0.020 |
Why?
|
| Aerobiosis | 2 | 1977 | 19 | 0.020 |
Why?
|
| Chloramphenicol | 3 | 1979 | 7 | 0.020 |
Why?
|
| Teicoplanin | 1 | 1986 | 5 | 0.020 |
Why?
|
| Staphylococcus epidermidis | 1 | 1986 | 12 | 0.020 |
Why?
|
| Penicillin Resistance | 1 | 1986 | 12 | 0.020 |
Why?
|
| Coagulase | 1 | 1986 | 14 | 0.020 |
Why?
|
| Simplexvirus | 1 | 1986 | 26 | 0.020 |
Why?
|
| Acyclovir | 1 | 1986 | 38 | 0.020 |
Why?
|
| Glycopeptides | 1 | 1986 | 15 | 0.020 |
Why?
|
| Vancomycin | 1 | 1986 | 60 | 0.020 |
Why?
|
| Biopsy | 1 | 1987 | 539 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 1986 | 175 | 0.020 |
Why?
|
| Physical Examination | 1 | 1986 | 152 | 0.020 |
Why?
|
| Cephalothin | 2 | 1987 | 5 | 0.020 |
Why?
|
| Education, Medical, Undergraduate | 1 | 1986 | 148 | 0.010 |
Why?
|
| Tetracycline | 2 | 1975 | 29 | 0.010 |
Why?
|
| Pregnancy | 4 | 1981 | 2334 | 0.010 |
Why?
|
| Students, Medical | 1 | 1985 | 210 | 0.010 |
Why?
|
| Tobramycin | 1 | 1982 | 38 | 0.010 |
Why?
|
| Paromomycin | 1 | 1981 | 3 | 0.010 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 1981 | 7 | 0.010 |
Why?
|
| Giardiasis | 1 | 1981 | 7 | 0.010 |
Why?
|
| Abscess | 3 | 1982 | 37 | 0.010 |
Why?
|
| Thienamycins | 1 | 1981 | 4 | 0.010 |
Why?
|
| Bacteria | 2 | 1973 | 193 | 0.010 |
Why?
|
| Middle Aged | 3 | 2000 | 21119 | 0.010 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 1981 | 92 | 0.010 |
Why?
|
| Mixed Function Oxygenases | 1 | 2000 | 35 | 0.010 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2000 | 22 | 0.010 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2000 | 62 | 0.010 |
Why?
|
| North Carolina | 1 | 2000 | 224 | 0.010 |
Why?
|
| Male | 6 | 2000 | 37283 | 0.010 |
Why?
|
| Lipoproteins, HDL | 1 | 2000 | 113 | 0.010 |
Why?
|
| Cefamandole | 1 | 1979 | 5 | 0.010 |
Why?
|
| Endometritis | 1 | 1979 | 29 | 0.010 |
Why?
|
| Bacteroides Infections | 1 | 1979 | 3 | 0.010 |
Why?
|
| Universities | 1 | 2000 | 191 | 0.010 |
Why?
|
| Meningitis | 1 | 1979 | 23 | 0.010 |
Why?
|
| Female | 9 | 2000 | 38021 | 0.010 |
Why?
|
| Penicillin G | 2 | 1979 | 8 | 0.010 |
Why?
|
| Lactobacillus | 1 | 1977 | 6 | 0.010 |
Why?
|
| Streptococcus | 1 | 1977 | 15 | 0.010 |
Why?
|
| Cervix Uteri | 1 | 1977 | 64 | 0.010 |
Why?
|
| Vagina | 1 | 1977 | 87 | 0.010 |
Why?
|
| beta-Lactamase Inhibitors | 1 | 1976 | 9 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 1985 | 1533 | 0.010 |
Why?
|
| Tetracyclines | 1 | 1975 | 3 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 1979 | 2455 | 0.010 |
Why?
|
| Minocycline | 1 | 1975 | 61 | 0.010 |
Why?
|
| Aminoglycosides | 2 | 1972 | 54 | 0.010 |
Why?
|
| Kinetics | 1 | 1976 | 1047 | 0.010 |
Why?
|
| Cephaloridine | 1 | 1973 | 2 | 0.010 |
Why?
|
| Drug Therapy, Combination | 3 | 1982 | 648 | 0.010 |
Why?
|
| Bacteriological Techniques | 1 | 1973 | 49 | 0.010 |
Why?
|
| Kanamycin | 1 | 1972 | 11 | 0.010 |
Why?
|
| Adult | 5 | 2000 | 21379 | 0.010 |
Why?
|
| Abortion, Septic | 1 | 1972 | 1 | 0.010 |
Why?
|
| Lincomycin | 1 | 1972 | 4 | 0.010 |
Why?
|
| Moxalactam | 2 | 1982 | 3 | 0.010 |
Why?
|
| Lung Abscess | 1 | 1972 | 4 | 0.010 |
Why?
|
| Brain Abscess | 1 | 1972 | 7 | 0.010 |
Why?
|
| Erythromycin | 1 | 1972 | 13 | 0.010 |
Why?
|
| Endocarditis, Bacterial | 1 | 1972 | 32 | 0.010 |
Why?
|
| Oxygen | 1 | 1973 | 386 | 0.010 |
Why?
|
| Sepsis | 1 | 1972 | 233 | 0.010 |
Why?
|
| L Forms | 1 | 1987 | 1 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1986 | 49 | 0.000 |
Why?
|
| Culture Media | 1 | 1987 | 155 | 0.000 |
Why?
|
| Opportunistic Infections | 1 | 1986 | 33 | 0.000 |
Why?
|
| Herpes Simplex | 1 | 1986 | 35 | 0.000 |
Why?
|
| DNA, Viral | 1 | 1986 | 114 | 0.000 |
Why?
|
| Physician-Patient Relations | 1 | 1986 | 261 | 0.000 |
Why?
|
| Imipenem | 1 | 1981 | 9 | 0.000 |
Why?
|
| beta-Lactams | 1 | 1981 | 29 | 0.000 |
Why?
|
| Fetal Monitoring | 1 | 1979 | 20 | 0.000 |
Why?
|
| Labor, Obstetric | 1 | 1979 | 23 | 0.000 |
Why?
|
| Nafcillin | 1 | 1979 | 3 | 0.000 |
Why?
|
| Infusions, Parenteral | 1 | 1979 | 47 | 0.000 |
Why?
|
| Fetal Blood | 1 | 1979 | 131 | 0.000 |
Why?
|
| Cellulitis | 1 | 1979 | 13 | 0.000 |
Why?
|
| Escherichia coli Infections | 1 | 1979 | 47 | 0.000 |
Why?
|
| Streptococcal Infections | 1 | 1979 | 53 | 0.000 |
Why?
|
| Fever | 1 | 1979 | 96 | 0.000 |
Why?
|
| Peritonitis | 1 | 1979 | 46 | 0.000 |
Why?
|
| Biliary Tract Diseases | 1 | 1979 | 50 | 0.000 |
Why?
|
| Risk | 1 | 1979 | 563 | 0.000 |
Why?
|
| Time Factors | 1 | 1986 | 4655 | 0.000 |
Why?
|
| R Factors | 1 | 1975 | 8 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1979 | 848 | 0.000 |
Why?
|
| Aged | 2 | 1982 | 14842 | 0.000 |
Why?
|
| Mice | 1 | 1986 | 8474 | 0.000 |
Why?
|
| Methods | 1 | 1973 | 156 | 0.000 |
Why?
|
| Cross Infection | 1 | 1974 | 195 | 0.000 |
Why?
|
| Health Education | 1 | 1974 | 279 | 0.000 |
Why?
|
| Animals | 1 | 1986 | 20880 | 0.000 |
Why?
|